REDUCE LAP-HF III Corvia Protocol 1701 (REDUCELAPHFIII)
A Post-Market Clinical Follow-up Study to Evaluate the Corvia Medical, Inc. InterAtrial Shunt Device - IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Jan Komtebedde, DVM
- Phone Number: 978-654-6113
- Email: jkomtebedde@corviamedical.com
Study Contact Backup
- Name: Felix DeLaRosa
- Email: fdelarosa@corviamedical.com
Study Locations
-
-
-
Bad Nauheim, Germany
- Herzzentrum der Kerckhoff-Klinik
-
Bad Oeynhausen, Germany
- Herz- und Diabeteszentrum Nordrhein-Westfalen Klinik für Kardiologie
-
Bad Segeberg, Germany
- Segeberger Kliniken GmbH
-
Berlin, Germany
- Unfallkrankenhaus Berlin
-
Chemnitz, Germany
- Klinikum Chemnitz gGmbH
-
Cologne, Germany
- Herzzentrum der Universität zu Köln
-
Detmold, Germany
- Klinikum Lippe GmbH
-
Dresden, Germany
- Herzzentrum Dresden GmbH
-
Düsseldorf, Germany
- Universitätsklinikum Düsseldorf Klinik für Kardiologie, Pneumologie u. Angiologie
-
Essen, Germany
- Elisabeth-Krankenhaus Essen
-
Giessen, Germany
- Universitätsklinikum Gießen
-
Göttingen, Germany
- Universitätsklinikum Göttingen
-
Halle, Germany
- Universitäts Klinikum Halle
-
Heilbronn, Germany
- Klinikum am Plattenwald Bad Friedrichshall
-
Karlsburg, Germany
- Klinikum Karlsburg
-
Kiel, Germany
- Klinik für Innere Medizin III mit den Schwerpunkten Kardiologie, Angiologie und internistische
-
Leipzig, Germany
- Klinikum Sankt Georg
-
Lübeck, Germany
- Universitatsklinikum Schleswig-Holstein
-
Münster, Germany
- Universitätsklinikum Münster
-
Osnabrück, Germany
- Niels-Stensen-Kliniken - Marienhospital
-
Paderborn, Germany
- St Vincenz-Kranenhaus
-
Rotenburg (Wümme), Germany
- Herz-Kreislauf-Zentrum Rotenburg
-
Schwerin, Germany, 19049
- Helios Kliniken Schwerin
-
Wittenberg, Germany
- Evangelisches Krankenhaus Paul Gerhardt Stift - Unfallstation
-
Zwickaü, Germany
- Heinrich Braun Klinikum
-
Ülm, Germany
- Universitätsklinik Ulm-Keßler
-
-
-
-
-
Solothurn, Switzerland
- Bürgelspital Solothurn
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serious Adverse Events
Time Frame: 30 days
|
Device and or procedure related serious adverse cardiac events
|
30 days
|
|
New York Heart Classification
Time Frame: 12 months
|
Improvement in NYHA Classification
|
12 months
|
|
Quality of Life Improvement (KCCQ score)
Time Frame: 12 months
|
Improvement in KCCQ score
|
12 months
|
|
Quality of Life Improvement (EQ5D)
Time Frame: 12 months
|
Improvement in EQ5D score
|
12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1701
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.